The potential for further gains appears to be limited for shares in EssilorLuxottica which are trading close to the resistance at 130 EUR. These price levels could engender some profit taking. Investors should open a short trade and target the € 124.2.
The company usually posts poor financials for mid or long term investments.
For a short-term investment strategy, the company has poor fundamentals.
The stock is close to a major daily resistance at EUR 130, which should be gotten rid of so as to gain new appreciation potential.
With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
With an expected P/E ratio at 383.29 and 36.64 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Revenue estimates are regularly revised downwards for the current and coming years.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
ę MarketScreener.com 2021
Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.